![]() | |
Clinical data | |
---|---|
Other names | SNC-80 |
Identifiers | |
| |
CAS Number | |
PubChemCID | |
IUPHAR/BPS | |
ChemSpider |
|
UNII | |
ChEBI | |
ChEMBL | |
CompTox Dashboard(EPA) | |
Chemical and physical data | |
Formula | C28H39N3O2 |
Molar mass | 449.639 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
SNC-80 is anopioidanalgesic compound that selectively activates μ–δ opioid receptorheteromers[1] and is used primarily in scientific research.[2] Discovered in 1994, SNC-80 was a pioneering non-peptide compound regarded as a highly selective agonist for the δ-opioid receptor.[3]
SNC-80 was the first non-peptide compound developed that was regarded as a highly selectiveagonist for theδ-opioidreceptor.[4]It has been shown to produce usefulanalgesic,[5]antidepressant[6] andanxiolytic effects in animal studies,[7][8] but its usefulness is limited by producingconvulsions at high doses,[9] and so SNC-80 is not used medically, although it is a useful compound in scientific research.